Rajasekaran Mahalingam
The University of Texas MD Anderson Cancer Center
ORCID: 0000-0003-2228-5628Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 12 papers. Top paper: “STAT3 Inhibition to Treat Ulcerative Colitis-Associated Colorectal Cancer”.
Zal Italia, Zara Italia, Tan Hoang, Emma Rodrı́guez, T. Kris Eckols +6 more
Alexandre V. Seua, Pooja Singhmar, Luis D. Arroyo, Rajasekaran Mahalingam, Jian Hu +3 more
Rajasekaran Mahalingam, Anand Kumar Singh, Shruti Dharmaraj, Taylor T. Chrisikos, Nabila Boukelmoune +3 more
Rajasekaran Mahalingam, Hari Krishna Yalamanchili, Tingting Weng, Harry Karmouty‐Quintana, Ashrith Guha +2 more
Rajasekaran Mahalingam, Silvia Squillace, Kenneth A. Jacobson, Dilip K. Tosh, Shruti Dharmaraj +5 more
Neha Arora, Md. Areeful Haque, Drew Weis, Ronnie The Phong Trinh, Sanjay V. Neerukonda +10 more
Rajasekaran Mahalingam, Mayela Carolina Mendt, Luis G. Arroyo, Alexandre V. Seua, Shruti Dharmaraj +3 more
Emmanuel Martínez-Ledesma, Jian‐Wen Dong, Rajasekaran Mahalingam, Soon Young Park, Yuji Piao +5 more
Hoang Vu Pham, Eric Lee, Rajasekaran Mahalingam, Andrew J. Shepherd, James M. Nichols
Yuan Pan, Peter M. Grace, Cobi J. Heijnen, Rajasekaran Mahalingam, T. Acharya
Wang Shan, Marcin Dulęba, Suchan Niroula, Kristina Göller, Jingzhong Xie +21 more
Blake McAlpin, Anand Kumar Singh, Cobi J. Heijnen, Rajasekaran Mahalingam, Vena K. Martinez